argus

Advanced Enzyme Technologies Limited

NSE: ADVENZYMESINE837H01020₹3,312 Cr

Timeline

Time (IST)TypeMEventSrc
12 Nov, 10:33 am—…Advanced Enzyme Technologies Ltd - 540025 - Standalone And Consolidated Financial Results For Quarter And Half Year Ended September 30, 2025bse
12 Nov, 10:27 am—…Advanced Enzyme Technologies Ltd - 540025 - Board Meeting Outcome for Board Meeting Outcomebse
12 Nov, 10:26 am—…Advanced Enzyme Technologies Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.nse
10 Nov, 03:07 pm—…Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the Company will host a Conference call for Analysts and Investors to discuss the Un-audited financial results of the Company for the quarter ended September 30, 2025 on Thursday, November 13, 2025 at 04:00 p.m. (IST)nse
04 Nov, 02:38 pm—…Advanced Enzyme Technologies Ltd - 540025 - Board Meeting Intimation for Approval Of The Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30 September 2025bse
07 Oct, 11:02 am—…Advanced Enzyme Technologies Limited has informed the Exchange regarding allotment of 45650 securities pursuant to ESOP/ESPS at its meeting held on October 07, 2025nse
22 Sept, 02:23 pm—…Advanced Enzyme Technologies Limited has informed the Exchange about Investor Presentationnse
22 Sept, 02:14 pm—…Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
19 Sept, 06:20 pm—…Please find enclosed herewith intimation with respect to Pharma and Healthcare conference - by DAM Capital Advisors Limitednse